TREA

79252897 - IMMODULON

Follow

Information

  • Trademark
  • 79252897
  • Serial Number
    79252897
  • Registration Number
    5946864
  • Filing Date
    September 24, 2018
    6 years ago
  • Registration Date
    December 31, 2019
    5 years ago
  • Transaction Date
    December 31, 2024
    2 months ago
  • Status Date
    December 31, 2019
    5 years ago
  • Published for Opposition Date
    October 15, 2019
    5 years ago
  • Location Date
    December 31, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DICKSON, RACHAEL
  • Attorney Name
    Alexandra MacKay
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
3
Mark Identification
IMMODULON
Case File Statements
  • DM0000: The mark consists of the stylized wording "IMMODULON", where "IMM" is in white and surrounded by a shaded teal circle and "ODULON" is in dark blue. All other instances of the color white in the mark represent background and/or transparent areas only and are not claimed as features of the mark.
  • GS0051: Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations
  • CC0000: The color(s) dark blue, teal, and white is/are claimed as a feature of the mark.
  • GS0441: Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition
  • GS0421: Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation
Case File Event Statements
  • 2/28/2019 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/8/2019 - 6 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 3/11/2019 - 6 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/11/2019 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/12/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/13/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/15/2019 - 5 years ago
    7 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/21/2019 - 5 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/21/2019 - 5 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/6/2019 - 5 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/9/2019 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/9/2019 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/10/2019 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/11/2019 - 5 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/12/2019 - 5 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 9/25/2019 - 5 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/25/2019 - 5 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 9/25/2019 - 5 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/12/2019 - 5 years ago
    19 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 10/15/2019 - 5 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/15/2019 - 5 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/31/2019 - 5 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/31/2020 - 4 years ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/16/2020 - 4 years ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/16/2020 - 4 years ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/8/2020 - 4 years ago
    26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/31/2024 - 2 months ago
    27 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3